Atlas Trials

Radiotherapy Combined With Realgar-Indigo Naturalis Formula (RIF) in the Treatment of Rhabdomyosarcoma(RMS) in Children

Clinical trial NCT05708391 · UNKNOWN

Trial details

NCT number
NCT05708391
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Rhabdomyosarcoma, Child
Start date
2023-01-31
Primary completion
2024-03-31
Enrollment
53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.